Senlizumab
Based on 1 Customer Validation
Senlizumab is a humanized antibody expressed in CHO cells that targets TNFSF2/TNFa. Senlizumab is composed of huIgG4SP heavy chains and huκ light chains, with a predicted molecular weight (MW) of 146.9 kDa. The isotype control for Senlizumab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 95.09%
- No. CAS: 336128-48-4
- Peso molecular:146.868 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
Human IgG4 kappa
Human
TNFSF2/TNFa
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
ELISA, FACS, Functional assay
-
Immobilized TNF-alpha/TNFSF2 Protein, Human (HY-P7058) can bind Senlizumab. The EC50 for this effect is 38.20 ng/mL.
Chemical Information
-
No. CAS 336128-48-4
-
Appearance Liquid
-
Peso molecular 146.868 kDa
-
Color Colorless to light yellow
-
SMILES
[Senlizumab]
-
Synonyms
BAY-103356; CDP-571
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (230 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)